The obsessive compulsive disorder;Le trouble obsessionnel compulsif

Medecine/Sciences

Volumn 29, Issue 12, 2013, Pages 1111-1116

  Flores Alves Dos Santos, João ^a,b   Mallet, Luc ^b,c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Hopital Albert Chenevier   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; AMINO ACID RECEPTOR BLOCKING AGENT;

BRAIN DEPTH STIMULATION; COMORBIDITY; GENETIC DISORDER; HUMAN; MULTIMODALITY CANCER THERAPY; OBSESSIVE-COMPULSIVE DISORDER; PSYCHOTHERAPY; OBSESSIVE COMPULSIVE DISORDER; REVIEW;

COMBINED MODALITY THERAPY; COMORBIDITY; DEEP BRAIN STIMULATION; EXCITATORY AMINO ACID ANTAGONISTS; GENETIC DISEASES, INBORN; HUMANS; NEUROTRANSMITTER AGENTS; OBSESSIVE-COMPULSIVE DISORDER; PSYCHOTHERAPY;

EID: 84893483296     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/20132912014     Document Type: Review

References (47)

1. Stein DJ. Obsessive-compulsive disorder. Lancet 2002; 360: 397-405.
2. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National comorbidity survey replication. Arch Gen Psychiatry 2005; 62: 593-602.
3. Abramowitz JS, Taylor S, McKay D. Obsessive-compulsive disorder. Lancet 2009; 374: 491-499.
4. Taylor S. Early versus late onset obsessive-compulsive disorder: evidence for distinct subtypes. Clin Psychol Rev 2011; 31: 1083-1100.
5. Katerberg H, Delucchi KL, Stewart SE, et al. Symptom dimensions in OCD: item-level factor analysis and heritability estimates. Behav Genet 2010; 40: 505-517.
6. Weissman MM, Bland RC, Canino GJ, et al. The cross national epidemiology of obsessive compulsive disorder. The Cross national collaborative group. J Clin Psychiatry 1994; 55: suppl 5-10.
7. Pallanti S. Transcultural observations of obsessive-compulsive disorder. Am J Psychiatry 2008; 165: 169-170.
8. Pauls DL. The genetics of obsessive-compulsive disorder: a review. Dialogues Clin Neurosci 2010; 12: 149-163.
9. Welch JM, Lu J, Rodriguiz RM, et al. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature 2007; 448: 894-900.
10. Nestadt G, Grados M, Samuels JF. Genetics of obsessive-compulsive disorder. Psychiatr Clin North Am 2010; 33: 141-158.
11. Rotge JY, Aouizerate B, Tignol J, et al. The glutamate-based genetic immune hypothesis in obsessive-compulsive disorder. An integrative approach from genes to symptoms. Neuroscience 2010; 165: 408-417.
12. De Leeuw AS, Westenberg HGM. Hypersensitivity of 5-HT2 receptors in OCD patients. J Psychiatr Res 2008; 42: 894-901.
13. Chakrabarty K, Bhattacharyya S, Christopher R, et al. Glutamatergic dysfunction in OCD. Neuropsychopharmacology 2005; 30: 1735-1740.
14. MacMaster FP, O'Neill J, Rosenberg DR. Brain imaging in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 2008; 47: 1262-1272.
15. Haynes WIA, Mallet L. High-frequency stimulation of deep brain structures in obsessive-compulsive disorder: the search for a valid circuit. Eur J Neurosci 2010; 32: 1118-1127.
16. Taj MJRJ, Viswanath B, Purushottam M, et al. DRD4 gene and obsessive compulsive disorder: Do symptom dimensions have specific genetic correlates? Prog Neuropsychopharmacol Biol Psychiatry 2013; 41: 18-23.
17. Aouizerate B, Guehl D, Cuny E, et al. Pathophysiology of obsessive-compulsive disorder: a necessary link between phenomenology, neuropsychology, imagery and physiology. Prog Neurobiol 2004; 72: 195-221.
18. Murphy TK, Storch EA, Lewin AB, et al. Clinical factors associated with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. J Pediatr 2012; 160: 314-319.
19. Brilot F, Merheb V, Ding A, et al. Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndrome. Neurology 2011; 76: 1508-1513.
20. Rotge JY, Guehl D, Dilharreguy B, et al. Meta-analysis of brain volume changes in obsessive-compulsive disorder. Biol Psychiatry 2009; 65: 75-83.
21. Szeszko PR, Christian C, Macmaster F, et al. Gray matter structural alterations in psychotropic drug-naive pediatric obsessive-compulsive disorder: an optimized voxel-based morphometry study. Am J Psychiatry 2008; 165: 1299-1307.
22. Whiteside SP, Port JD, Abramowitz JS. A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Res 2004; 132: 69-79.
23. Rotge JY, Langbour N, Jaafari N, et al. Anatomical alterations and symptom-related functional activity in obsessive-compulsive disorder are correlated in the lateral orbitofrontal cortex. Biol Psychiatry 2010; 67: e37-e38.
24. Zarei M, Mataix-Cols D, Heyman I, et al. Changes in gray matter volume and white matter microstructure in adolescents with obsessive-compulsive disorder. Biol Psychiatry 2011; 70: 1083-1090.
25. Worbe Y, Baup N, Grabli D, et al. Behavioral and movement disorders induced by local inhibitory dysfunction in primate striatum. Cerebral Cortex 2009; 19: 1844-1856.
26. Grabli D. Behavioural disorders induced by external globus pallidus dysfunction in primates. I. Behavioural study. Brain 2004; 127: 2039-2054.
27. Karachi C, Grabli D, Baup N, et al. Dysfunction of the subthalamic nucleus induces behavioral and movement disorders in monkeys. Mov Disord 2009; 24: 1183-1192.
28. Pallanti S, Quercioli L. Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 400-412.
29. Bloch MH, Landeros-Weisenberger A, Kelmendi B, et al. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 2006; 11: 622-632.
30. Komossa K, Depping AM, Meyer M, et al. Second-generation antipsychotics for obsessive compulsive disorder. Cochrane Database Syst Rev 2010: CD008141.
31. Abramowitz JS. The psychological treatment of obsessive-compulsive disorder. Can J Psychiatry 2006; 51: 407-416.
32. Storch EA, Mariaskin A, Murphy TK. Psychotherapy for obsessive-compulsive disorder. Curr Psychiatry Rep 2009; 11: 296-301.
33. Foa EB, Franklin ME, Moser J. Context in the clinic: how well do cognitive-behavioral therapies and medications work in combination?. Biol Psychiatry 2002; 52: 987-997.
34. Storch EA, Murphy TK, Goodman WK, et al. A Preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry 2010; 68: 1073-1076.
35. Nuttin B, Cosyns P, Demeulemeester H, et al. Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder. Lancet 1999; 354: 1526.
36. Denys D, Mantione M, Figee M, et al. Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 2010; 67: 1061-1068.
37. Aouizerate B, Cuny E, Martin-Guehl C, et al. Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depression. Case report. J Neurosurg 2004; 101: 682-686.
38. Mallet L, Polosan M, Jaafari N, et al. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med 2008; 359: 2121-2134.
39. Mallet L, Mesnage V, Houeto JL, et al. Compulsions, Parkinson's disease, and stimulation. Lancet 2002; 360: 1302-1304.
40. Mundt A, Klein J, Joel D, et al. High-frequency stimulation of the nucleus accumbens core and shell reduces quinpirole-induced compulsive checking in rats. Eur J Neurosci 2009; 29: 2401-2412.
41. Baup N, Grabli D, Karachi C, et al. High-frequency stimulation of the anterior subthalamic nucleus reduces stereotyped behaviors in primates. J Neurosci 2008; 28: 8785-8788.
42. Bloch MH, Landeros-Weisenberger A, Rosario MC, et al. Meta-analysis of the symptom structure of obsessive-compulsive disorder. Am J Psychiatry 2008; 165: 1532-1542.
43. Mataix-Cols D, Rosario-Campos MCD, Leckman JF. A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry 2005; 162: 228-238.
44. Harrison BJ, Pujol J, Cardoner N, et al. Brain corticostriatal systems and the major clinical symptom dimensions of obsessive-compulsive disorder. Biol Psychiatry 2013; 73: 321-328.
45. Aouizerate B, Martin-Guehl C, Cuny E, et al. Stimulation cérébrale profonde du striatum ventral dans le traitement du trouble obsessionnel-compulsif avec dépression majeure. Med Sci (Paris) 2005; 21: 811-813.
46. Epelbaum J., Pour les tics et tocs, serait-ce SLITRK1 ? Med Sci (Paris) 2005; 21: 1117.
47. Jupille J. Le trouble déficitaire de l'attention avec hyperactivité. Med Sci (Paris) 2011; 27: 318-322.